Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases

BACKGROUND: Radioactive iodine 131 ((131)I) therapy has long been used in the treatment of differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications secondary to (131)I therapy are well documented, there is little in the literature addressing nasolacrimal duct obstruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Qahtani, Khalid Hussain, Al Asiri, Mushabbab, Tunio, Mutahir A, Aljohani, Naji J, Bayoumi, Yasser, Munir, Iqbal, AlAyoubi, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266423/
https://www.ncbi.nlm.nih.gov/pubmed/25525325
http://dx.doi.org/10.2147/OPTH.S71708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266423/
https://www.ncbi.nlm.nih.gov/pubmed/25525325
http://dx.doi.org/10.2147/OPTH.S71708

Ejemplares similares